Tag Archives: William M Mitchell
Effect of disease duration in a randomized phase III trial of rintatolimod, an immune modulator for ME/CFS
Effect of disease duration in a randomized Phase III trial of rintatolimod, an immune modulator for Myalgic Encephalomyelitis/Chronic Fatigue Syndrome, by David R Strayer, Diane Young, William M Mitchell in PLoS ONE 15(10): e0240403, Oct 29 2020 [doi.org/10.1371/journal.pone.0240403] Research … Continue reading
Posted in News
Tagged ampligen, David R Strayer, Diane Young, exercise tolerance testing, exercise treadmill tolerance, Intention to treat analysis, Rintatolimod, William M Mitchell
Comments Off on Effect of disease duration in a randomized phase III trial of rintatolimod, an immune modulator for ME/CFS
